Auxergen, Inc. — Form D/A
Auxergen, Inc. of BALITMORE, MD, a company, filed a Form D amendment with the SEC on 2023-05-05. The offering totals $1.0M, of which $535K was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-05-05
- Form: D/A
- Accession: 0001853250-23-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $535K
- Remaining: $465K
- Minimum investment: $25K
- Investors: 11
- Date of first sale: 2021-04-05
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-396191
Issuer
- Name: Auxergen, Inc.
- CIK: 0001853250
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 701 EAST PRATT STREET, BALITMORE, MD, 21202
- Phone: 4439299757
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Gregory Contreras | Director | Baltimore, MD |
| Ting Yu-Yeh | Director | Baltimore, MD |
| Gregory Contreras | Executive Officer | Baltimore, MD |
| Ting Yu-Yeh | Executive Officer | Baltimore, MD |
Other filings by this issuer (2)
More